Coming Soon: Ever-More-Concentrated Varieties of Insulin. Buyers Beware!

Recently, Lilly held what it called its second diabetes social media summit, although in truth, the company did not fly anyone into Indianapolis for the first summit, so in reality, this was the company's first.  I was not invited, which frankly doesn't surprise me, because I've been critical of the company and I honestly think they're terrified of me - seriously, they were looking for people who wouldn't challenge them on much (like their decision to outsource some insulin manufacturing away from its own plant in Indianapolis to Hospira in McPherson, Kansas only to bring it back in-house this year), and that's probably not me.  I ask pharma difficult questions and they prefer bloggers who generally won't challenge them on such issues.On Twitter, the hashtag #LDSummit13 has some of the Tweets from participants regarding the Lilly summit.  DiabetesMine covered it HERE.Having said that, Lilly really just kind of danced around the topic of glucose-responsive insulin, and company executive David Moller made a point of noting that Lilly had an active research program on smart insulin, claiming "we are looking at the science that would allow us to pursue it in a smart way".  However, both he and David Kendall kind of bad-mouthed the concept saying "Smart insulin was 'aspirational' and over-hyped on timeframe."See the following Tweet:Smart insulin is "aspirational," over-hyped on timeframe. But faster insulin is doable, & next. -David Moller &amp...
Source: Scott's Web Log - Category: Diabetes Authors: Source Type: blogs